Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
William N. Malatestinic
ResearcherPublications, citations & collaboration network
William N. Malatestinic is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 57 works, 530 citations, an h-index of 13 and an i10-index of 20.
57
Works
530
Citations
13
h-index
20
i10-index
How has William N. Malatestinic's publication output changed over time?
ScholarIQpublication output · 2017–2022
Output grew0% over the shown period — from 1 works in 2017 to 1 in 2022.
1
2
2
3
2
1
201720182019202020212022
What are the most-cited papers on William N. Malatestinic?
ScholarIQmost cited works
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study
Gil Yosipovitch, Peter Foley, Caitriona Ryan, Jennifer Clay Cather, K.A.P. Meeuwis, Russel Burge, Alison Potts Bleakman, Chen-Yen Lin, William N. Malatestinic, Alice B. Gottlieb
S159512450. 201852 CitationsOPEN ACCESS
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab
Andrew Blauvelt, Nianwen Shi, Russel Burge, William N. Malatestinic, Chen‐Yen Lin, Carolyn R. Lew, Nicole M. Zimmerman, Orin M. Goldblum, Baojin Zhu, Mwangi J. Murage
S58727509. 201946 Citations
Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry
Benjamin Lockshin, Angel M. Cronin, Ryan W. Harrison, Robert R. McLean, Laura Anatale‐Tardiff, Russel Burge, Baojin Zhu, William N. Malatestinic, Bilal Atiya, Mwangi J. Murage, Gaia Gallo, Bruce Strober, Abby Van Voorhees
S67424211. 202146 CitationsOPEN ACCESS
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis
S. Al Sawah, Shonda A. Foster, Orin M. Goldblum, William N. Malatestinic, Baojin Zhu, Nianwen Shi, Xue Song, Steven R. Feldman
Journal of Medical Economics. 201744 CitationsOPEN ACCESS
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization
April W. Armstrong, Shonda A. Foster, Brian S. Comer, Chen‐Yen Lin, William N. Malatestinic, Russel Burge, Orin M. Goldblum
S151902004. 201832 CitationsOPEN ACCESS
Related on ScholarIQ
Eli Lilly (United States)
Institution
Ixekizumab Improved Patient-Reported Genital Psoriasis Symptoms and Impact of Symptoms on Sexual Activity vs Placebo in a Randomized, Double-Blind Study
Paper
Comparison of real-world treatment patterns among patients with psoriasis prescribed ixekizumab or secukinumab
Paper
Drug survival of ixekizumab, TNF inhibitors, and other IL‐17 inhibitors in real‐world patients with psoriasis: The Corrona Psoriasis Registry
Paper
Healthcare costs in psoriasis and psoriasis sub-groups over time following psoriasis diagnosis
Paper
Real-world health outcomes in adults with moderate-to-severe psoriasis in the United States: a population study using electronic health records to examine patient-perceived treatment effectiveness, medication use, and healthcare resource utilization
Paper